ClinicalTrials.Veeva

Menu

Application of Genomic Techniques and Image Processing Using Artificial Intelligence to Obtain a Predictor Model Risk of Melanoma

M

Maimónides Biomedical Research Institute of Córdoba

Status

Unknown

Conditions

Melanoma

Study type

Observational

Funder types

Other

Identifiers

NCT02511119
JRR-MEL-2015

Details and patient eligibility

About

The aim of this study is to develop a predictive model of risk of developing melanoma. The investigators will used artificial intelligence techniques to analysed images patterns obtained by clinical and dermoscopic pictures. The investigators want to defined a new predictive risk model obtained from genetic information and image analysis of pigmented lesions. This model could help to discriminate more accurately those patients who are most likely to develop melanoma in a high-risk population.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥18 years of age;
  • Followed up patients in the Pigmented Lesions Unit at Reina Sofia University Hospital with high risk of developing melanoma (First-degree family/personal history of familiar melanoma and/or melanocyticnevi above 50 and/or dysplastic or atypical nevi);
  • All nevi for which there is at least one dermatoscopy registry will be included.

Exclusion criteria

  • not enough data in the patient clinical history;
  • located lesions on the face, scalp, mucous membrane or on acral área;
  • nodular or metastatic melanoma diagnosis
  • type V or VI of Fitzpatrick phototyping scale

Trial contacts and locations

0

Loading...

Central trial contact

Blanca Quijano-Ruiz, Pharmacist

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems